🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
The purpose of this study is to estimate overall survival (OS) for particip...
Status
Completed
Location
Local Institution
Start Date
2019-09-16
Trial ID
NCT05421299
This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-07-07
Trial ID
NCT01951885
Treatments Being Tested
This is a pilot study to demonstrate that the modified LMB-89 treatment reg...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1994-11
Trial ID
NCT00187161
Treatments Being Tested
This study aims to compare efficacy of methotrexate vs apremilast in the ma...
Status
Recruiting
Location
MTI-HMC Peshawar
Start Date
2025-12-25
Trial ID
NCT07337434
Treatments Being Tested
In the proposed study, escalating doses of inotuzumab ozogamicin will be ad...
Status
Unknown
Location
Vanderbilt-Ingram Cancer Center
Start Date
2022-07-22
Trial ID
NCT03962465
This is a randomized study of the safety and tolerability of multiple doses...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT01011959
Treatments Being Tested
Naïve CD4+ helper T (Th) cells, upon encountering their cognate antigens pr...
Status
Completed
Location
Rheumatology department - Bordeaux University Hospital
Start Date
2014-09
Trial ID
NCT02569736
The aim of this study is to evaluate the efficacy and safety of AZT and MTX...
Status
Completed
Location
Pak Emirates Military Hospital
Start Date
2024-07-14
Trial ID
NCT06476366
Treatments Being Tested
Methotrexate (MTX), a folic acid analogue, inhibits the synthesis of purine...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-01
Trial ID
NCT06872073